Disease State: B-ALL

Dr. Girnius – #1

By

Dr. Dan Douer

By

Dr. Elias Jabbour – #1

By

Dr. Elias Jabbour – #2

By

Dr. Jessica Leonard

By

Almost half of clonoSEQ-tested patients receive the Clonality (ID) test using a fresh sample.

By

Patients are receiving longer-term MRD monitoring with clonoSEQ.

By

Nearly half of all patients who receive clonoSEQ MRD testing are monitored more frequently than once per year.

By

The demographics of clonoSEQ-tested patients are consistent with overall disease demographics.

By

Pediatric B-ALL case studies

By

    Opt-in to receive future email communications regarding clonoSEQ

      

    I'm interested in:


    How did you learn about clonoSEQ?

    By checking the “I agree” box, you agree we can send you information about clonoSEQ (you’ll have the option to easily unsubscribe any time) and that you are 18 years of age or older.

    I am a registered user, please take me to the Diagnostic Portal.

    Log In

    I am a new user and need to request a new account

    Request Account

    Please select your location to continue:

    United States Outside the U.S.